Egalet Corporation

Egalet (NASDAQ: EGLT) is developing erosion-based, drug abuse resistant and controlled release oral drug delivery technologies for pain management. The company’s mission is to help ensure access to effective medications for individuals living with chronic pain while protecting physicians, families and communities from the burden of abuse.

Headquarters Vaerlose, Denmark
Website www.egalet.com​
Pipeline Multiple candidates from IND to Phase 3